Liang Zeng

机构：Central South University, The First People's Hospital of Changde · ORCID：0000-0002-4517-7470

发表论文 115 篇 · 总被引 3177 次 · h-index 29

代表论文

• Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy (2023 · Journal of Hematology & Oncology · 被引 106)
• SDC1-TGM2-FLOT1-BHMT complex determines radiosensitivity of glioblastoma by influencing the fusion of autophagosomes with lysosomes (2023 · Theranostics · 被引 33)
• Validation of E1L3N antibody for PD-L1 detection and prediction of pembrolizumab response in non-small-cell lung cancer (2022 · Communications Medicine · 被引 20)
• Bispecific Antibody Targeting VEGF/TGF‐β Synergizes with Local Radiotherapy: Turning Tumors from Cold to Inflamed and Amplifying Abscopal Effects (2025 · Advanced Science · 被引 18)
• Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China (2024 · Cancer Immunology Immunotherapy · 被引 16)
• Copy number variations mediate major pathological response to induction chemo-immunotherapy in unresectable stage IIIA-IIIB lung cancer (2023 · Lung Cancer · 被引 8)